In our previous study, GJE containing 400 mg/kg of geniposide demonstrated protective effects against non-steroidal anti-inflammatory drugs (NSAID)-induced gastropathy in rats by downregulating inducible nitric oxide synthase (iNOS) and transcription factor nuclear factor kappa-B (NF-κB) under acute conditions [9]. The gene discussed is NOS2; the disease is stomach disorder.